We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$265M
AUM Growth
+$45.6M
Cap. Flow
+$35M
Cap. Flow %
13.21%
Top 10 Hldgs %
72.11%
Holding
24
New
1
Increased
20
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
ENTA icon
Enanta Pharmaceuticals
ENTA
+$11M
2
OFIX icon
Orthofix Medical
OFIX
+$7.35M
3
AVNS
Avanos Medical
AVNS
+$5.93M
4
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$5.36M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.81M

Top Sells

Rank Stock Value
1
AMAG
AMAG Pharmaceuticals
AMAG
+$18.6M
2
ABBV icon
AbbVie
ABBV
+$4.1M

Sector Composition

Rank Sector Weight
1 Healthcare 72.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTA icon
1
Enanta Pharmaceuticals
ENTA
$366M
$31.8M 11.99%
706,908
+282,892
+67% +$11M
UTHR icon
2
United Therapeutics
UTHR
$25.8B
$25.9M 9.77%
148,858
+18,057
+14% +$3.25M
IPXL
3
DELISTED
Impax Laboratories, Inc.
IPXL
$20.9M 7.89%
455,475
+44,531
+11% +$2.11M
TEVA icon
4
Teva Pharmaceuticals
TEVA
$40.8B
$18.3M 6.91%
309,962
+61,762
+25% +$3.81M
AVNS
5
DELISTED
Avanos Medical
AVNS
$17.7M 6.66%
436,243
+132,093
+43% +$5.93M
OFIX icon
6
Orthofix Medical
OFIX
$477M
$17.3M 6.54%
523,447
+213,749
+69% +$7.35M
SCMP
7
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$15.9M 5.99%
967,404
+33,538
+4% +$582K
CNMD icon
8
CONMED
CNMD
$1.39B
$15.5M 5.83%
265,428
+14,154
+6% +$763K
MRK icon
9
Merck
MRK
$322B
$12.6M 4.77%
232,764
+13,413
+6% +$752K
SRGA
10
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$11.4M 4.31%
59,002
+2,287
+4% +$425K
HRC
11
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$10.8M 4.08%
199,113
+10,786
+6% +$560K
AMGN icon
12
Amgen
AMGN
$208B
$10.6M 4%
69,086
+12,086
+21% +$1.94M
ASRT
13
DELISTED
Assertio
ASRT
$7.79M 2.94%
6,048
+322
+6% +$441K
IVC
14
DELISTED
Invacare Corporation
IVC
$7.65M 2.88%
353,632
+18,870
+6% +$400K
AGN
15
DELISTED
Allergan plc
AGN
$7.07M 2.67%
23,290
+1,336
+6% +$398K
SPPI
16
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$5.77M 2.18%
+843,702
New +$5.36M
VXRT
17
DELISTED
Vaxart
VXRT
$3.39M 1.28%
148,954
+25,622
+21% +$629K
INVA icon
18
Innoviva
INVA
$1.55B
$3.08M 1.16%
170,308
+9,120
+6% +$157K
JNP
19
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$3M 1.13%
327,617
+11,468
+4% +$86.6K
STRR
20
DELISTED
Star Equity Holdings
STRR
$1.92M 0.73%
8,862
+470
+6% +$98.1K
FURX
21
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$1.42M 0.54%
145,544
– –
ABBV icon
22
AbbVie
ABBV
$443B
– –
-70,000
Closed -$4.1M
AMAG
23
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-341,091
Closed -$18.6M

Similar funds

CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
JFG
Juno Financial Group Richmond, Virginia $255M AUM
PIP
Palisades Investment Partners Santa Monica, California $255M AUM 50.52% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
GAMC
Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return
TIA
Tiemann Investment Advisors Menlo Park, California $255M AUM 21.35% 1-Year Est. Return

Krensavage Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Krensavage Asset Management held 24 positions worth $265M, up 21% from $220M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Krensavage Asset Management deployed $35M of net new capital in Q2 2015, opening 1 new position and adding to 20 existing holdings. Its largest new stake was Spectrum Pharmaceuticals Inc: 843,702 shares worth $5.77M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 67% a quarter earlier.

On the sell side, the most notable exit was AMAG Pharmaceuticals, an estimated $18.6M sold.

  • Krensavage Asset Management's largest Q2 2015 buy was Spectrum Pharmaceuticals Inc: 843,702 shares worth $5.77M.
  • Krensavage Asset Management added most to Enanta Pharmaceuticals in Q2 2015, an estimated $11M increase.
  • Krensavage Asset Management fully exited AMAG Pharmaceuticals in Q2 2015, selling an estimated $18.6M.
  • Krensavage Asset Management's ten largest holdings make up 72% of its $265M portfolio in Q2 2015.
  • Krensavage Asset Management opened 1 new position and closed 2 in Q2 2015.
  • Krensavage Asset Management's portfolio value rose 21% quarter-over-quarter to $265M.

Based on Krensavage Asset Management's 13F filing for Q2 2015, filed 13 Aug 2015.